Hugh O’Neill named as Chief Commercial Officer

SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Hugh O’Neill as Chief Commercial Officer. O’Neill brings over 30 years of experience in the pharmaceutical industry. Most recently, Mr. O’Neill served as the Executive Vice President with…

Details

SCA Pharma Awarded Multi-Year Contract with Vizient, Supporting Better Drug Accessibility

Windsor, CT, November 1, 2022– SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced today that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products. Vizient is one of the nation’s leading health…

Details

SCA Pharma Names Louis Pace as Chief Financial Officer and Chief Information Officer

SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Louis Pace as Chief Financial Officer and Chief Information Officer. Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and P&L…

Details

Racheal Adams to participate in FDA’s Compounding Quality Center of Excellence Virtual Conference

SCA Pharma Director of Corporate Quality Racheal Adams, will join leading industry experts for the FDA’s 2021 Compounding Quality Center of Excellence Virtual Conference titled “Culture of Quality” being held September 13-15. The virtual conference will bring together outsourcing facilities, regulators and industry leadership to engage on emerging industry topics and best practices to improve…

Details